MEI Pharma, Inc. (MEIP)

MEI Pharma Balance Sheet

Financials in millions USD. Fiscal year is July - June.

Year	2023	2022	2021	2020	2019
Cash & Equivalents	16.91	15.74	153.43	182.63	74.49
Short-Term Investments	83.79	137.51	0	0	0
Cash & Cash Equivalents	100.69	153.25	153.43	182.63	74.49
Cash Growth	-34.30%	-0.11%	-15.99%	145.18%	-27.50%
Receivables	0.09	10.04	7.58	2.86	0
Other Current Assets	6.75	3.83	3.81	23.16	7.71
Total Current Assets	107.53	167.13	164.82	208.64	82.2
Property, Plant & Equipment	13.28	10.71	9.28	1.08	0.2
Goodwill and Intangibles	0	0	0	0	0.26
Total Long-Term Assets	13.28	10.71	9.28	1.08	0.47
Total Assets	120.81	177.84	174.1	209.73	82.66
Accounts Payable	6.13	7.92	6.36	2.44	4.79
Deferred Revenue	64.86	95.44	79.22	83.66	7.77
Current Debt	1.43	0.87	0.93	0	0
Other Current Liabilities	-52.08	-79.79	-66.29	-72.34	1.74
Total Current Liabilities	20.34	24.44	20.21	13.76	14.3
Long-Term Debt	11.3	8.77	7.37	0	0
Other Long-Term Liabilities	64.55	92.21	97.05	118.91	20.43
Total Long-Term Liabilities	75.85	100.98	104.42	118.91	20.43
Total Liabilities	96.19	125.43	124.63	132.67	34.73
Total Debt	12.73	9.64	8.3	0	0
Debt Growth	32.01%	16.20%	-	-	-
Retained Earnings	-406	-374.16	-319.71	-278.39	-231.22
Shareholders' Equity	24.62	52.41	49.47	77.06	47.93
Net Cash / Debt	87.97	143.61	145.13	182.63	74.49
Net Cash / Debt Growth	-38.75%	-1.05%	-20.53%	145.18%	-27.50%
Net Cash Per Share	13.20	22.95	25.35	40.10	20.58
Working Capital	87.19	142.68	144.61	194.89	67.9
Book Value Per Share	3.70	8.42	8.79	16.92	13.47

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).